2016 Hematological Malignancies
HD16 GHSG trial for early favorable HL
CS I/II without RF*
Experimental Arms
20 Gy IF 2 x ABVD PET (+/-) Standard Arm
2 x ABVD PET- Follow-up
2 x ABVD PET+ 20 Gy IF
*a) large mediastinal mass; b) extranodal disease; c) high ERS; d) 3 or more areas
GHSG 2010
Made with FlippingBook